Navigation Links
BioVigil Releases Second-Generation Hand Hygiene Monitoring System
Date:3/16/2010

SANTA ROSA, Calif., March 16 /PRNewswire/ -- BioVigil LLC has released the second generation of the BioVigil hand hygiene monitoring system. The innovative system enables hospitals to more effectively combat Hospital-Acquired Infections (HAIs) by dramatically increasing hand hygiene compliance among healthcare workers.  

HAIs waste over $20-30 billion each year, with as many as one in ten hospital patients picking up a secondary infection while spending time in a hospital. Infections are particularly dangerous for patients recovering from surgery, with as many as 99,000 deaths per year in the United States alone attributed to HAIs.

According to the U.S. Centers for Disease Control (CDC), hand hygiene is the single most effective way to combat hospital-acquired infections. As a result, 34 states have implemented standards which require hospitals to improve on hand hygiene.

The second-generation BioVigil system incorporates innovative badge technology and related sensors to effectively monitor hand hygiene compliance in hospitals. The system verifies the use of hand sanitizer in every patient's room, and records compliance data in a secure database.

"Our second-generation system solves the accuracy problems that are inherent in RF-based sensors," explains Brian Sheahan, Chief Executive Officer for BioVigil LLC. "An RF-based system does not have the accuracy and sensitivity which our system offers. We know with 100% accuracy when a healthcare worker enters and exits a location. Our system is simple, cost-effective and saves lives.

"In addition, the BioVigil system uses an alcohol sensor on the ID badge of the healthcare worker, so that a nurse or doctor can simply enter a patient's room, then use hand sanitizer while approaching the patient's bed and interacting with the patient. We have been able to design a sensor network which makes the system highly user-friendly and patient-friendly. The bright green and red LEDs embedded in the ID badge enable other healthcare personnel and even patients to easily see whether a healthcare worker is in compliance."

Mr. Sheahan noted that BioVigil completed an IRB-approved trial with VCU Medical Center during September 2009, validating the successful operation of its second-generation BV-140 technology. Dr. Michael Edmond of VCU Medical Center will be presenting results of the trial at the Society for Healthcare Epidemiology of America (SHEA) conference in Atlanta, GA on Sunday, March 21, 2010 at 11:45 a.m.

BioVigil (http://www.biovigil.org), based in Santa Rosa, California, has a number of patents which protect its proprietary approach at hand hygiene detection and reporting. The company has refined its unique approach to hand hygiene compliance over four years of development activity and repeated trials.    

    
    
    Contact: 
    
    Joe Madden
    BioVigil
    (707) 508-9170
    biovigil@comcast.net 

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.

SOURCE BioVigil LLC

Back to top

RELATED LINKS
http://www.biovigil.org

'/>"/>

SOURCE BioVigil LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
2. Providence Service Corporation Releases Fourth Quarter and Year End 2009 Results
3. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
4. Pi2 Solutions Releases the Latest Version of its Product Literature Database System for the Biopharmaceutical Industry
5. CEL-SCI Corporation Releases Letter to Shareholders
6. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
7. SpectraScience Releases Shareholder Newsletter
8. Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics
9. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
10. ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
11. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Summary Breast cancer, a malignant neoplasm, is ... cancer in women worldwide, accounting for 16% of all ... of women diagnosed with breast cancer has increased over ... has declined due to earlier diagnosis and better treatment ... the past four decades, especially with increasing usage of ...
(Date:2/4/2016)... MOUNTAIN VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... supply management solutions to healthcare systems, today announced results ... 2015.  --> --> ... was $130.3 million, up $5.1 million or 4.1% from ... or 7.2% from the fourth quarter of 2014. Revenue ...
(Date:2/4/2016)... , Feb. 4, 2016 In response to the ... FDA,s Deputy Commissioner for Medical Products and Tobacco, along with ... reassess the agency,s approach to opioid medications. The plan will ... providing patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at ... of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, and ... , For Valentine’s Day, not only are long-stem roses available, but also other flower ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... ... February 05, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... again host, Swirl, A Wine Tasting Event at the La Gorce Country Club ...
(Date:2/5/2016)... Dallas, Texas (PRWEB) , ... February 05, 2016 , ... ... to allow users to search for and donate to Give To Cure’s campaign ... is an app that lets users make and share payments through a smart device. ...
(Date:2/5/2016)... MA (PRWEB) , ... February 05, 2016 , ... ... in tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, ... option with unmatched results. , Developed by Cynosure, the PicoSure has been approved by ...
Breaking Medicine News(10 mins):